SignatureFD’s iRadimed IRMD Stock Holding History

SignatureFD’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63K	Sell	17 -4	-19%	-$364	﹤0.01%	3175
2026 Q1	$2.02K	Buy	21 +8	+62%	+$800	﹤0.01%	3058
2025 Q4	$1.26K	Sell	13 -14	-52%	-$1.2K	﹤0.01%	3079
2025 Q3	$1.92K	Buy	27 +20	+286%	+$1.33K	﹤0.01%	2966
2025 Q2	$419	Sell	7 -9	-56%	-$493	﹤0.01%	3130
2025 Q1	$840	Buy	16 +9	+129%	+$506	﹤0.01%	3074
2024 Q4	$385	Hold	7	–	–	﹤0.01%	3166
2024 Q3	$352	Buy	+7	New	+$323	﹤0.01%	3135
2024 Q2	–	Sell	-1	Closed	-$44	–	3188
2024 Q1	$44	Hold	1	–	–	﹤0.01%	3132
2023 Q4	$47	Buy	+1	New	+$42	﹤0.01%	3098
2023 Q3	–	Sell	-3	Closed	-$143	–	3251
2023 Q2	$143	Buy	+3	New	+$135	﹤0.01%	3160
2022 Q3	–	Sell	-34	Closed	-$1K	–	3216
2022 Q2	$1K	Sell	34 -61	-64%	-$2.19K	﹤0.01%	2934
2022 Q1	$4K	Sell	95 -1	-1%	-$46	﹤0.01%	2591
2021 Q4	$4K	Buy	96 +47	+96%	+$1.9K	﹤0.01%	2488
2021 Q3	$2K	Buy	+49	New	+$1.67K	﹤0.01%	2658

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SignatureFD's IRMD Position: Q2 2026 in Review

SignatureFD reduced its iRadimed (IRMD) stake by 19% in Q2 2026, selling an estimated $364 and leaving 17 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

SignatureFD first reported a position in IRMD in Q3 2021 and has held it in 15 quarters since. The position peaked at $4K in Q1 2022. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

SignatureFD held 17 shares of iRadimed worth $1.63K as of Q2 2026.
SignatureFD sold 4 iRadimed shares in Q2 2026, an estimated $364.
iRadimed made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3175 holding.
SignatureFD first reported a position in iRadimed in Q3 2021 and has held it in 15 quarters since.
SignatureFD's iRadimed position peaked at $4K in Q1 2022.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.